Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877.

Antonia RJ, Castillo J, Herring LE, Serafin DS, Liu P, Graves LM, Baldwin AS, Hagan RS.

Sci Rep. 2019 Sep 17;9(1):13470. doi: 10.1038/s41598-019-49707-8.

2.

Increased Noise in Cortico-Cortical Integration After Mild TBI Measured With the Equivalent Noise Technique.

Ruiz T, Baldwin AS, Spiegel DP, Hess R, Farivar R.

Front Neurol. 2019 Jul 18;10:767. doi: 10.3389/fneur.2019.00767. eCollection 2019.

3.

Assessment of stereovision with digital testing in adults and children with normal and impaired binocularity.

Tittes J, Baldwin AS, Hess RF, Cirina L, Wenner Y, Kuhli-Hattenbach C, Ackermann H, Kohnen T, Fronius M.

Vision Res. 2019 Nov;164:69-82. doi: 10.1016/j.visres.2019.07.006. Epub 2019 Sep 4.

PMID:
31377344
4.

Trait mindfulness and health behaviours: a meta-analysis.

Sala M, Rochefort C, Lui PP, Baldwin AS.

Health Psychol Rev. 2019 Aug 11:1-49. doi: 10.1080/17437199.2019.1650290. [Epub ahead of print]

PMID:
31362588
5.

Visual plasticity and exercise revisited: No evidence for a "cycling lane".

Finn AE, Baldwin AS, Reynaud A, Hess RF.

J Vis. 2019 Jun 3;19(6):21. doi: 10.1167/19.6.21.

PMID:
31246227
6.

Ocular dominance plasticity: A binocular combination task finds no cumulative effect with repeated patching.

Min SH, Baldwin AS, Hess RF.

Vision Res. 2019 Aug;161:36-42. doi: 10.1016/j.visres.2019.05.007. Epub 2019 Jun 18.

PMID:
31194984
7.

The Effects of Positive Affect and Episodic Future Thinking on Temporal Discounting and Healthy Food Demand and Choice Among Overweight and Obese Individuals: Protocol for a Pilot 2×2 Factorial Randomized Controlled Study.

Levens SM, Sagui-Henson SJ, Padro M, Martin LE, Trucco EM, Cooperman NA, Baldwin AS, Kassianos AP, Mdege ND.

JMIR Res Protoc. 2019 Mar 20;8(3):e12265. doi: 10.2196/12265.

8.

IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.

Carneiro-Lobo TC, Scalabrini LC, Magalhães LDS, Cardeal LB, Rodrigues FS, Dos Santos EO, Baldwin AS, Levantini E, Giordano RJ, Bassères DS.

Lung Cancer. 2019 Apr;130:169-178. doi: 10.1016/j.lungcan.2019.02.027. Epub 2019 Feb 25.

PMID:
30885340
9.

Cholinergic Potentiation Alters Perceptual Eye Dominance Plasticity Induced by a Few Hours of Monocular Patching in Adults.

Sheynin Y, Chamoun M, Baldwin AS, Rosa-Neto P, Hess RF, Vaucher E.

Front Neurosci. 2019 Jan 31;13:22. doi: 10.3389/fnins.2019.00022. eCollection 2019.

10.

The shift in ocular dominance from short-term monocular deprivation exhibits no dependence on duration of deprivation.

Min SH, Baldwin AS, Reynaud A, Hess RF.

Sci Rep. 2018 Nov 20;8(1):17083. doi: 10.1038/s41598-018-35084-1.

11.

Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer.

Durand JK, Zhang Q, Baldwin AS.

Cells. 2018 Sep 15;7(9). pii: E139. doi: 10.3390/cells7090139. Review.

12.

Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2.

Tegowski M, Fan C, Baldwin AS.

J Biol Chem. 2018 Oct 12;293(41):15977-15990. doi: 10.1074/jbc.RA118.003719. Epub 2018 Aug 21.

13.

VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma.

Zhang J, Wu T, Simon J, Takada M, Saito R, Fan C, Liu XD, Jonasch E, Xie L, Chen X, Yao X, Teh BT, Tan P, Zheng X, Li M, Lawrence C, Fan J, Geng J, Liu X, Hu L, Wang J, Liao C, Hong K, Zurlo G, Parker JS, Auman JT, Perou CM, Rathmell WK, Kim WY, Kirschner MW, Kaelin WG Jr, Baldwin AS, Zhang Q.

Science. 2018 Jul 20;361(6399):290-295. doi: 10.1126/science.aap8411.

14.

Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia.

Damrauer JS, Stadler ME, Acharyya S, Baldwin AS, Couch ME, Guttridge DC.

Eur J Transl Myol. 2018 Jun 6;28(2):7590. doi: 10.4081/ejtm.2018.7590. eCollection 2018 Apr 24.

15.

IKK promotes cytokine-induced and cancer-associated AMPK activity and attenuates phenformin-induced cell death in LKB1-deficient cells.

Antonia RJ, Baldwin AS.

Sci Signal. 2018 Jul 10;11(538). pii: eaan5850. doi: 10.1126/scisignal.aan5850.

PMID:
29991651
16.

Reducing "I Don't Know" Responses and Missing Survey Data: Implications for Measurement.

Denman DC, Baldwin AS, Betts AC, McQueen A, Tiro JA.

Med Decis Making. 2018 Aug;38(6):673-682. doi: 10.1177/0272989X18785159. Epub 2018 Jul 2.

17.

Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.

Porrello A, Leslie PL, Harrison EB, Gorentla BK, Kattula S, Ghosh SK, Azam SH, Holtzhausen A, Chao YL, Hayward MC, Waugh TA, Bae S, Godfrey V, Randell SH, Oderup C, Makowski L, Weiss J, Wilkerson MD, Hayes DN, Earp HS, Baldwin AS, Wolberg AS, Pecot CV.

Nat Commun. 2018 May 18;9(1):1988. doi: 10.1038/s41467-018-04355-w.

18.

Parent-Provider Communication of HPV Vaccine Hesitancy.

Shay LA, Baldwin AS, Betts AC, Marks EG, Higashi RT, Street RL Jr, Persaud D, Tiro JA.

Pediatrics. 2018 Jun;141(6). pii: e20172312. doi: 10.1542/peds.2017-2312. Epub 2018 May 15.

19.

Experiential Avoidance: An Examination of the Construct Validity of the AAQ-II and MEAQ.

Rochefort C, Baldwin AS, Chmielewski M.

Behav Ther. 2018 May;49(3):435-449. doi: 10.1016/j.beth.2017.08.008. Epub 2017 Sep 1.

PMID:
29704971
20.
21.

The equivalent internal orientation and position noise for contour integration.

Baldwin AS, Fu M, Farivar R, Hess RF.

Sci Rep. 2017 Oct 12;7(1):13048. doi: 10.1038/s41598-017-13244-z.

22.

Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.

Thomas C, Henry W, Cuiffo BG, Collmann AY, Marangoni E, Benhamo V, Bhasin MK, Fan C, Fuhrmann L, Baldwin AS, Perou C, Vincent-Salomon A, Toker A, Karnoub AE.

Sci Signal. 2017 Feb 21;10(467). pii: eaah4674. doi: 10.1126/scisignal.aah4674.

23.

Targeting IKK and NF-κB for Therapy.

Durand JK, Baldwin AS.

Adv Protein Chem Struct Biol. 2017;107:77-115. doi: 10.1016/bs.apcsb.2016.11.006. Epub 2017 Jan 11. Review.

PMID:
28215229
24.

Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity.

Hsia HC, Hutti JE, Baldwin AS.

J Biol Chem. 2017 Mar 31;292(13):5405-5417. doi: 10.1074/jbc.M116.771964. Epub 2017 Feb 10.

25.

Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome.

Fowler KA, Jania CM, Tilley SL, Panoskaltsis-Mortari A, Baldwin AS, Serody JS, Coghill JM.

Biol Blood Marrow Transplant. 2017 Apr;23(4):569-580. doi: 10.1016/j.bbmt.2017.01.083. Epub 2017 Feb 1.

26.

Ocular dominance plasticity: inhibitory interactions and contrast equivalence.

Spiegel DP, Baldwin AS, Hess RF.

Sci Rep. 2017 Jan 10;7:39913. doi: 10.1038/srep39913.

27.

Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection.

Hsia HC, Stopford CM, Zhang Z, Damania B, Baldwin AS.

J Leukoc Biol. 2017 Apr;101(4):1053-1064. doi: 10.1189/jlb.4A1016-199RR. Epub 2016 Dec 13.

28.

Translating self-persuasion into an adolescent HPV vaccine promotion intervention for parents attending safety-net clinics.

Baldwin AS, Denman DC, Sala M, Marks EG, Shay LA, Fuller S, Persaud D, Lee SC, Skinner CS, Wiebe DJ, Tiro JA.

Patient Educ Couns. 2017 Apr;100(4):736-741. doi: 10.1016/j.pec.2016.11.014. Epub 2016 Nov 20.

29.

The Relationship Between Fusion, Suppression, and Diplopia in Normal and Amblyopic Vision.

Spiegel DP, Baldwin AS, Hess RF.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5810-5817. doi: 10.1167/iovs.16-20438.

PMID:
27802486
30.

Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.

Lawrence CL, Baldwin AS.

PLoS One. 2016 Oct 20;11(10):e0165005. doi: 10.1371/journal.pone.0165005. eCollection 2016.

31.

IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.

Rinkenbaugh AL, Cogswell PC, Calamini B, Dunn DE, Persson AI, Weiss WA, Lo DC, Baldwin AS.

Oncotarget. 2016 Oct 25;7(43):69173-69187. doi: 10.18632/oncotarget.12507.

32.

Modification and validation of the Treatment Self Regulation Questionnaire to assess parental motivation for HPV vaccination of adolescents.

Denman DC, Baldwin AS, Marks EG, Lee SC, Tiro JA.

Vaccine. 2016 Sep 22;34(41):4985-4990. doi: 10.1016/j.vaccine.2016.08.037. Epub 2016 Aug 29.

33.

Characterizing safety-net providers' HPV vaccine recommendations to undecided parents: A pilot study.

Shay LA, Street RL Jr, Baldwin AS, Marks EG, Lee SC, Higashi RT, Skinner CS, Fuller S, Persaud D, Tiro JA.

Patient Educ Couns. 2016 Sep;99(9):1452-60. doi: 10.1016/j.pec.2016.06.027. Epub 2016 Jun 25.

34.

Cardiorespiratory fitness moderates the effect of an affect-guided physical activity prescription: a pilot randomized controlled trial.

Baldwin AS, Kangas JL, Denman DC, Smits JA, Yamada T, Otto MW.

Cogn Behav Ther. 2016 Nov;45(6):445-57. doi: 10.1080/16506073.2016.1194454. Epub 2016 Jun 16.

PMID:
27310568
35.

The role of rational and experiential processing in influencing the framing effect.

Stark E, Baldwin AS, Hertel AW, Rothman AJ.

J Soc Psychol. 2017;157(3):308-321. doi: 10.1080/00224545.2016.1198301. Epub 2016 Jun 7.

PMID:
27269813
36.

The NF-κB Pathway and Cancer Stem Cells.

Rinkenbaugh AL, Baldwin AS.

Cells. 2016 Apr 6;5(2). pii: E16. doi: 10.3390/cells5020016. Review.

37.

PI3K/Akt promotes feedforward mTORC2 activation through IKKα.

Dan HC, Antonia RJ, Baldwin AS.

Oncotarget. 2016 Apr 19;7(16):21064-75. doi: 10.18632/oncotarget.8383.

38.

Rejecting probability summation for radial frequency patterns, not so Quick!

Baldwin AS, Schmidtmann G, Kingdom FAA, Hess RF.

Vision Res. 2016 May;122:124-134. doi: 10.1016/j.visres.2016.03.003. Epub 2016 May 2.

39.

What Do Contrast Threshold Equivalent Noise Studies Actually Measure? Noise vs. Nonlinearity in Different Masking Paradigms.

Baldwin AS, Baker DH, Hess RF.

PLoS One. 2016 Mar 8;11(3):e0150942. doi: 10.1371/journal.pone.0150942. eCollection 2016.

40.

Statistical models for multilevel skewed physical activity data in health research and behavioral medicine.

Baldwin SA, Fellingham GW, Baldwin AS.

Health Psychol. 2016 Jun;35(6):552-62. doi: 10.1037/hea0000292. Epub 2016 Feb 15.

PMID:
26881287
41.

Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.

Bagó JR, Alfonso-Pecchio A, Okolie O, Dumitru R, Rinkenbaugh A, Baldwin AS, Miller CR, Magness ST, Hingtgen SD.

Nat Commun. 2016 Feb 2;7:10593. doi: 10.1038/ncomms10593.

42.

Developing a Tablet-Based Self-Persuasion Intervention Promoting Adolescent HPV Vaccination: Protocol for a Three-Stage Mixed-Methods Study.

Tiro JA, Lee SC, Marks EG, Persaud D, Skinner CS, Street RL, Wiebe DJ, Farrell D, Bishop WP, Fuller S, Baldwin AS.

JMIR Res Protoc. 2016 Jan 29;5(1):e19. doi: 10.2196/resprot.5092.

43.
44.

Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells.

Zhang J, Li L, Baldwin AS Jr, Friedman AD, Paz-Priel I.

PLoS One. 2015 Jun 23;10(6):e0130441. doi: 10.1371/journal.pone.0130441. eCollection 2015.

45.
46.

The efficiency of second order orientation coherence detection.

Baldwin AS, Husk JS, Edwards L, Hess RF.

Vision Res. 2015 Apr;109(Pt A):45-51. doi: 10.1016/j.visres.2015.01.026. Epub 2015 Mar 4.

47.

Using RNA interference in lung cancer cells to target the IKK-NF-κB pathway.

Bassères DS, Baldwin AS.

Methods Mol Biol. 2015;1280:447-58. doi: 10.1007/978-1-4939-2422-6_27.

PMID:
25736766
48.

Examining the moderating effect of depressive symptoms on the relation between exercise and self-efficacy during the initiation of regular exercise.

Kangas JL, Baldwin AS, Rosenfield D, Smits JA, Rethorst CD.

Health Psychol. 2015 May;34(5):556-65. doi: 10.1037/hea0000142. Epub 2014 Aug 11.

49.

Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα).

Dan HC, Ebbs A, Pasparakis M, Van Dyke T, Basseres DS, Baldwin AS.

J Biol Chem. 2014 Sep 5;289(36):25227-40. doi: 10.1074/jbc.M114.554881. Epub 2014 Jul 2.

50.

IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.

Bassères DS, Ebbs A, Cogswell PC, Baldwin AS.

Genes Cancer. 2014 Apr;5(1-2):41-55.

Supplemental Content

Loading ...
Support Center